Related Experiment Videos
Aminoglycoside pharmacokinetics in African-Americans with normal renal function
E C Oparaoji1, S Siram, U Elemihe
1College of Pharmacy, Nursing and Allied Health, Howard University, Washington, DC 20059, USA.
Journal of Clinical Pharmacy and Therapeutics
|December 1, 1998
Summary
Aminoglycoside pharmacokinetics in African-Americans with normal renal function align with general population values. However, significant interpatient variability necessitates individualized dosing and close monitoring to prevent toxicity.
Area of Science:
- Pharmacokinetics and Pharmacodynamics
- Nephrology and Internal Medicine
Background:
- Aminoglycosides are crucial antibiotics for treating Gram-negative infections.
- Understanding population-specific pharmacokinetic parameters is vital for optimizing drug efficacy and safety.
- Previous studies have established aminoglycoside pharmacokinetic values in general adult populations.
Purpose of the Study:
- To compare aminoglycoside pharmacokinetic parameters in African-Americans with normal renal function against established adult population values.
- To evaluate the appropriateness of using population-based dosing guidelines for this demographic.
- To identify potential needs for individualized dosing strategies.
Main Methods:
- A prospective study was conducted at Howard University Hospital, enrolling 25 adult patients with normal renal function receiving aminoglycosides.
- Pharmacokinetic parameters including volume of distribution (Vd), half-life (t1/2), elimination rate constant (Ke), and total body clearance (Cl) were calculated using a one-compartment model.
- Patient pharmacokinetic values were compared to published general population data using an unpaired Student's t-test.
Main Results:
- Calculated pharmacokinetic values (Vd, t1/2, Ke, Cl) for aminoglycosides in African-Americans were not significantly different from general population values.
- Mean peak and trough serum drug levels were within therapeutic ranges following standard dosing.
- A wide interpatient variability in pharmacokinetic parameters was observed across the study population.
Conclusions:
- Aminoglycoside pharmacokinetics in African-Americans with normal renal function appear consistent with general population data.
- Population dosing guidelines are likely appropriate for initiating aminoglycoside therapy in this group.
- Close patient monitoring and individualized dosing are essential due to observed interpatient pharmacokinetic variability to mitigate toxicity.